|
|
Volumn 15, Issue 10, 2016, Pages 669-
|
|
Merck &Co. drops osteoporosis drug odanacatib
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIPHENYL DERIVATIVE;
BONE DENSITY CONSERVATION AGENT;
CATHEPSIN K;
CTSK PROTEIN, HUMAN;
ODANACATIB;
ANTAGONISTS AND INHIBITORS;
CLINICAL TRIAL (TOPIC);
DRUG INDUSTRY;
HUMAN;
OSTEOPOROSIS;
TRENDS;
BIPHENYL COMPOUNDS;
BONE DENSITY CONSERVATION AGENTS;
CATHEPSIN K;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
HUMANS;
OSTEOPOROSIS;
|
|
EID: 85013167848
PISSN: None
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd.2016.207 Document Type: Note |
|
Times cited : (109)
|
|
References (0)
|